Placing innovation in the hands of your surgeon
Mitre Medical is an early stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat mitral valve regurgitation (MR) and remodel the left ventricle (LV) in patients with moderate to severe MR.
![](https://www.mitremedical.com/wp-content/uploads/2018/01/Icon1.png)
The clinical need and economic opportunity
Treating and preventing Heart Failure (HF) is the goal of the $10B structural heart market – growing to $20B by 2028. HF is characterized by a 10% enlargement of the left ventricle (LV) every year.
![](https://www.mitremedical.com/wp-content/uploads/2018/01/Icon2.png)
Empowering surgeons
Surgeons have used our Mitral Touch to reverse this deadly trend of HF enlargement by
directly reducing the LV >30% in a beating heart without opening or stopping the heart.
![](https://www.mitremedical.com/wp-content/uploads/2018/01/Icon3.png)
Exceptional clinical Results
Using the Mitral Touch, surgeons have achieved
the greatest LV reduction ever published for a beating heart therapy. (Thourani et al., 2021)